Novo Nordisk A/S Site Gets Visit From Chinese Officials, Drug Probes Widen

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S, the world’s biggest maker of insulin, in the latest sign of a widening investigation into Western drugmakers. H. Lundbeck A/S, a smaller Danish drugs firm, also said its unit in Beijing had been visited by the authorities, while a Chinese newspaper reported an allegation from an unnamed person that French firm Sanofi SA had paid around 1.7 million yuan ($276,200) in bribes to hundreds of doctors in China in 2007. Paris-based Sanofi said it took the claim “very seriously”.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC